Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 28, 2020
View Archived Issues
AI finds structurally unique antibiotics
Read More
New dihydroquinoxalinone analogues targeting tubulin with promising preclinical antitumor action
Read More
New receptor tyrosine kinase inhibitor acts as a broad-spectrum coronavirus inhibitor in vitro
Read More
Neuronal necrosis induced by YAP deprivation mostly occurs in early stages of Alzheimer's disease
Read More
FDA approves Nexlizet tablet as first non-statin LDL-C lowering combination medicine
Read More
Positive top-line results for phase III ALLIUM study of Exblifep for cUTI
Read More
Novel alphaVbetea6-targeted PDC shows promise in preclinical models of PDAC
Read More
Progranulin as a novel prognostic biomarker in community-acquired pneumonia
Read More
Phase I data for novel lentiviral vector therapy for children with Fanconi anemia
Read More
First patient enrolled in first-in-human study of NI-006
Read More
Dosing begins in phase I study of KAN-101 for the treatment of celiac disease
Read More
CD5.CAR/28zeta CAR T cells show antitumor activity in relapsed/refractory T-cell lymphoma
Read More
FDA approves IND and grants orphan drug status for HBM-9167
Read More
Boehringer Ingelheim Pharma patents KLKB1 inhibitors
Read More
Microglial fresh start helps heal brain trauma
Read More
Inflazome divulges new NLRP3 inflammasome inhibitors
Read More
Leo Pharma A/S presents RORC ligands
Read More
Amgen and Carmot Therapeutics identify USP30 inhibitors
Read More
Epizyme discloses new SETD2 inhibitors
Read More
DNA-PKcs inhibitor increases the antitumor activity of localized DNA-damaging therapies
Read More
S1PR1 is required for tumor vascular normalization, enhancing the efficiency of antitumor agents
Read More
Clene announces interim blinded data from phase II study of CNM-Au8 for vision impairment in MS
Read More
Spark Therapeutics opens enrollment in phase I/II study of SPK-3006 in late-onset Pompe disease
Read More
FDA approves Nurtec ODT for acute treatment of migraine
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe